1.中国中医科学院广安门医院 北京 100053
2.中国中医科学院广安门医院科研处
3.中国中医科学院广安门医院肿瘤科
何善泉,男,在读硕士生
#李卫东,男,博士,副主任医师,硕士生导师,E-mail:liweidongdoctor@hotmail.com
纸质出版日期:2023-01-30,
收稿日期:2022-04-03,
移动端阅览
何善泉, 徐心瑶, 陈雪, 等. 从扶正解毒理论探讨中医药防治结直肠癌[J]. 现代中医临床, 2023,30(1):80-83.
HE Shanquan, XU Xinyao, CHEN Xue, et al. TCM prevention and treatment of colorectal cancer based on the theory of reinforcing healthy qi and resolving toxins[J]. Modern Chinese Clinical Medicine, 2023,30(1):80-83.
何善泉, 徐心瑶, 陈雪, 等. 从扶正解毒理论探讨中医药防治结直肠癌[J]. 现代中医临床, 2023,30(1):80-83. DOI: 10.3969/j.issn.2095-6606.2023.01.019.
HE Shanquan, XU Xinyao, CHEN Xue, et al. TCM prevention and treatment of colorectal cancer based on the theory of reinforcing healthy qi and resolving toxins[J]. Modern Chinese Clinical Medicine, 2023,30(1):80-83. DOI: 10.3969/j.issn.2095-6606.2023.01.019.
结直肠癌(CRC)是全球第三大常见恶性肿瘤。基于扶正解毒理论的中医药防治CRC有独特优势。中医药防治肿瘤及其复发转移的关键是提升患者正气,扶正不仅局限于提升患者的免疫系统防御能力,也与改善患者体内或者肠道内的内环境稳态,防止基因突变或提升抑癌基因相关,甚至与抑制肿瘤血管新生、调控肿瘤细胞自噬等机制相关。中医药解毒的机制可能在于改变肠道内部环境,降低炎症引起的氧化应激,防止炎症及氧化应激诱导的DNA突变,抑制肠癌细胞增殖以及促进肠癌细胞凋亡等。基于扶正解毒理论的中医药防治,在防治慢性肠炎癌变、减轻放化疗不良反应、防止CRC复发和转移方面,均有明确疗效。
Colorectal Cancer (CRC) is the third most common type of cancer in the world. Traditional Chinese medicine (TCM)
based on its theory of reinforcing healthy qi and resolving toxins
has unique advantages in preventing and treating CRC. The key to the prevention and treatment of cancer and its recurrence and metastasis is to strengthen the healthy qi of the patients. This is not only to improve the immune defense
but also to ameliorate the gut microbiota
prevent gene mutation and enhance expression of cancer suppressor genes. It can be even connected with inhibition of tumor angiogenesis
regulation of autophagy of tumor cells and so on. The mechanism of toxins removal of TCM may lie in the improvement of the intestinal environment
reduction of oxidative stress caused by inflammation
prevention of gene mutation induced by inflammation and oxidative stress
inhibition of the proliferation of colorectal cancer cells
and boosting of their apoptosis. Prevention and treatment by TCM based on the theory of reinforcing healthy qi and resolving toxins have been proven to be effective for preventing the canceration of chronic enteritis
reducing the adverse reactions of radiotherapy or chemotherapy
preventing the recurrence and metastasis of CRC and so on.
扶正解毒中医药结直肠癌防治
reinforcing healthy qiresolving toxinstraditional Chinese medicinecolorectal cancerprevention and treatment
NGUYEN M,TIPPING S S,LAM M, et al.An update on the use of immunotherapy in patients with colorectal cancer[J].Expert Rev Gastroenterol Hepatol,2021,15(3): 291-304.
SUI H,ZHANG L,GU K,et al.YYFZBJS ameliorates colorectal cancer progression in ApcMin/+ mice by remodeling gut microbiota and inhibiting regulatory T-cell generation[J/OL].Cell Commun Signal,2020,18(1):113[2022-03-17].https://doi.org/10.1186/s12964-020-00596-9.
ZHOU J Y,CHEN M,WU C E,et al. The modified Si-Jun-Zi Decoction attenuates colon cancer liver metastasis by increasing macrophage cells[J/OL].BMC Complement Altern Med,2019,19(1):86[2022-03-17].https://doi.org/10.1186/s12906-019-2498-4.
FENG W,AO H,YUE S,et al.Systems pharmacology reveals the unique mechanism features of Shenzhu Capsule for treatment of ulcerative colitis in comparison with synthetic drugs[J/OL].Sci Rep.2018,8(1):16160[2022-03-17].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212405/.
SUN X G,LIN X C,DIAO J X, et al.Pi (Spleen)-deficiency syndrome in tumor microenvironment is the pivotal pathogenesis of colorectal cancer immune escape[J].Chin J Integr Med,2016,22(10): 789-794.
王晓戎,张宏,袁孝兵,等.基于现代文献的大肠癌中医证候及病机研究[J].中国中医急症, 2009,18(11): 1859-1861.
DENG S,WANG A,CHEN X,et al.HBD inhibits the development of colitis-associated cancer in mice via the IL-6R/STAT3 signaling pathway[J/OL].Int J Mol Sci,2019,20(5):1069[2022-03-17].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429321/pdf/ijms-20-01069.pdf.
宁海容,陈建文,刘慰华,等.苍术合剂抗大鼠溃疡性结肠炎的作用及抗氧化机制研究[J].中山大学学报(医学科学版),2008,29(3s): 169-171.
邹颖,迟宏罡,戴世学,等.黄芩汤对湿热型溃疡性结肠炎大鼠Th1/Th2细胞因子的影响[J].时珍国医国药,2011,22(11): 2608-2611.
WANG X,SAUD S M,ZHANG X,et al. Protective effect of Shaoyao Decoction against colorectal cancer via the Keap1-Nrf2-ARE signaling pathway[J/OL].J Ethnopharmacol,2019,241:111981[2022-03-17].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC31146002/.
OSTRANG R S, SINHA P.Myeloid-derived suppressor cells:linking inflammation and cancer[J].J Immunol,2009,182(8): 4499-4506.
DIAZMONTERO C M,SALEM M L,NISHIMURA M I,et al.Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage,metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy[J].Cancer Immunol Immunother,2009,58(1): 49-59.
李培训,贾英杰,贾彦焘,等.参苓白术汤加减改善胃癌大肠癌术后脾虚证的观察[J].天津中医学院学报,2005,24(3): 151-152.
孟钰,武秀杰,李志超.中西医结合治疗结直肠癌根治术后复发转移疗效观察[J].临床心身疾病杂志,2018,24(3): 180-181.
胡佳奇,花宝金.花宝金教授运用气机升降理论防治化疗所致延迟性恶心、呕吐经验[J].中日友好医院学报,2020,34(1): 49-50.
陈文婷,刘宣,任建琳,等.基于聚类分析法的大肠癌术后患者中医用药规律研究[J].中华中医药学刊,2016,34(1): 101-104.
仝欣,徐川,于小伟,等.李敏教授从脾肾论治大肠癌术后临床经验[J].云南中医学院学报,2016,39(5): 86-89.
蒋益兰,潘敏求,蔡美.健脾消癌饮配合化疗拮抗大肠癌术后复发转移62例总结[J].湖南中医杂志,2007,23(1): 1-3.
李素云,周春仙,卫洪昌.扶正抑癌方含药血清对结肠癌LOVO细胞侵袭能力及TGF-β1与TβRⅡ蛋白表达的影响[J].上海中医药大学学报,2010,24(1): 68-71.
刘静,史勤,吕祥.健脾复方对人大肠癌移植瘤裸小鼠血管内皮生长因子及肿瘤微血管密度的影响[J].上海中医药杂志,2010,44(4): 62-65.
0
浏览量
85
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构